Pair Name | Sulforaphane, Metformin | ||
Phytochemical Name | Sulforaphane (PubChem CID: 5350 ) | ||
Anticancer drug Name | Metformin (PubChem CID: 4091 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Sulforaphane, Metformin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | CD44 | hsa960 | |
Down-regulation | Expression | CTNNB1 | hsa1499 | |
Down-regulation | Expression | ERBB2 | hsa2064 | |
Down-regulation | Expression | SRC | hsa6714 | |
Down-regulation | Expression | WNT1 | hsa7471 | |
In Vitro Model | BT-474 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0179 |
Result | Our data indicate that SLFN and MTFN can reduce cancer cell viability via both collaborative and differential effects and suggest that MTFN increases SLFN effectiveness by targeting common molecules/pathways downstream of HER2 and key for CSC signaling. |
No. | Title | Href |
---|---|---|
1 | Co-Treatment with Sulforaphane and Nano-Metformin Molecules Accelerates Apoptosis in HER2+ Breast Cancer Cells by Inhibiting Key Molecules. Nutr Cancer. 2020;72(5):835-848. doi: 10.1080/01635581.2019.1655073. | Click |